Envista Holdings NVST
NYSE NVST
$27.20 +0.27 (+1.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Envista Holdings (NVST) Asset Writedowns and Impairment (2019 - 2026)

Envista Holdings (NVST) posted quarterly Asset Writedowns and Impairment of $4.4 million for Q2 2026, up 238.46% year-over-year from $1.3 million in Q2 2025, and down 39.73% quarter-over-quarter from $7.3 million in Q4 2025.

Envista Holdings (NVST) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends

Envista Holdings' Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at $4.4 million for Q2 2026.

  • In Q2 2026, Asset Writedowns and Impairment rose 238.46% year-over-year to $4.4 million; the TTM figure through Apr 2026 stood at $11.7 million (down 98.99% YoY), while the FY2025 annual figure was $9.5 million, down 46.93% from the prior year.
  • Asset Writedowns and Impairment for Q2 2026 stood at $4.4 million, down from $7.3 million in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $1.2 billion in Q2 2024, with the low at -$3.3 million in Q4 2023.
  • The 5-year median for Asset Writedowns and Impairment is $2.0 million (2023), against an average of $98.2 million.
  • The sharpest annual moves came in 2023 and 2025: Asset Writedowns and Impairment slumped 466.67% in 2023, then jumped 284.21% in 2025.
  • Envista Holdings' Asset Writedowns and Impairment stood at $900000.0 in 2022, then plunged by 466.67% to -$3.3 million in 2023, then jumped by 157.58% to $1.9 million in 2024, then surged by 284.21% to $7.3 million in 2025, then slumped by 39.73% to $4.4 million in 2026.
  • Business Quant data shows NVST's Asset Writedowns and Impairment at $4.4 million in Q2 2026, $7.3 million in Q4 2025, and $1.3 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Envista Holdings 4.40 Bn 3.27 Bn 407.00 Mn

Historic Data

Download Data
DateValue
Jul 3, 2026 1.40 Mn
Jul 3, 2026 1.40 Mn
Apr 3, 2026 4.40 Mn
Apr 3, 2026 4.40 Mn
Dec 31, 2025 7.30 Mn
Dec 31, 2025 7.30 Mn
Mar 28, 2025 1.30 Mn
Mar 28, 2025 1.30 Mn
Dec 31, 2024 1.90 Mn
Dec 31, 2024 1.90 Mn
Jun 28, 2024 1.15 Bn
Jun 28, 2024 1.15 Bn
Mar 29, 2024 4.50 Mn
Mar 29, 2024 4.50 Mn
Dec 31, 2023 -3.30 Mn
Dec 31, 2023 -3.30 Mn
Mar 31, 2023 2.00 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 900,000.00
Dec 31, 2022 900,000.00